Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

NCT05267613 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis

Interventions

DRUG: Nexium 20mg
DRUG: Nexium 10mg

Sponsor

AstraZeneca

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]